Roswell Park Cancer Institute: Prostatic Neoplasms trials

The registry lists 31 Prostatic Neoplasms studies with Roswell Park Cancer Institute as lead sponsor. 4 are open to participants now and 8 have results posted.

Phase 1 8Phase 2 14Phase 3 2Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Transperineal Micro-ultrasound for the Detection of Prostate Cancer During BiopsyRecruitingNCT07075705Not applicable
• Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active SurveillanceRecruitingNCT06733350Phase 4
• Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialRecruitingNCT06563388Phase 3
• Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate CancerRecruitingNCT03880422Not applicable
• Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT02159950Phase 2Results posted
• Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerCompletedNCT00970203Phase 2Results posted
• Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00736645Phase 2Results posted
• Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate CancerTerminatedNCT00536991Phase 1/2Results posted
• Vitamin D in Treating Patients With Prostate CancerCompletedNCT00524680Phase 2Results posted
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00524589Phase 2Results posted
• Fulvestrant in Treating Patients With Recurrent Prostate CancerTerminatedNCT00217464Phase 2Results posted
• Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the ProstateTerminatedNCT00084864Phase 2Results posted
• Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT06305598Phase 1
• Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active SurveillanceCompletedNCT05764330Not applicable
• Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate CancerTerminatedNCT05037500Phase 1
• Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical ProstatectomySuspendedNCT04646434Not applicable
• Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryActive, not recruitingNCT03899987Phase 2
• Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03751436Phase 1
• Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate CancerWithdrawnNCT03709550Phase 1/2
• Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-TCompletedNCT01833208Not applicable
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
• Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerTerminatedNCT01174199Phase 1
• Guided Biopsy for Mapping Prostate CancerTerminatedNCT01007214Not applicable
• Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active SurveillanceWithdrawnNCT00796874Not applicable
• Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate CancerWithdrawnNCT00736164Phase 2
• Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapyWithdrawnNCT00559481Not applicable
• Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapyCompletedNCT00403000Phase 2
• Fulvestrant in Treating Patients With Advanced Prostate CancerCompletedNCT00244998Phase 2
• Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate CancerCompletedNCT00217516Phase 1
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation TherapyCompletedNCT00054522Phase 2
• Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical ProstatectomyCompletedNCT00003115Phase 3